The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein
ABSTRACT Following natural dengue virus (DENV) infection, humans produce some antibodies that recognize only the serotype of infection (type specific) and others that cross-react with all four serotypes (cross-reactive). Recent studies with human antibodies indicate that type-specific antibodies at...
Main Authors: | Scott A. Smith, A. Ruklanthi de Alwis, Nurgun Kose, Eva Harris, Kristie D. Ibarra, Kristen M. Kahle, Jennifer M. Pfaff, Xiaoxiao Xiang, Benjamin J. Doranz, Aravinda M. de Silva, S. Kyle Austin, Soila Sukupolvi-Petty, Michael S. Diamond, James E. Crowe |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2013-12-01
|
Series: | mBio |
Online Access: | https://journals.asm.org/doi/10.1128/mBio.00873-13 |
Similar Items
-
Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease.
by: Laura A Powell, et al.
Published: (2020-05-01) -
Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected].
by: Katherine L Williams, et al.
Published: (2013-02-01) -
Correction: In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection.
by: Ruklanthi de Alwis, et al.
Published: (2011-08-01) -
Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis
by: Jing Jin, et al.
Published: (2015-12-01) -
In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.
by: Ruklanthi de Alwis, et al.
Published: (2011-06-01)